These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22796357)

  • 1. Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes.
    Jindal HK; Merchant E; Balschi JA; Zhangand Y; Koren G
    J Proteomics; 2012 Sep; 75(17):5254-65. PubMed ID: 22796357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
    Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits.
    Liu GX; Choi BR; Ziv O; Li W; de Lange E; Qu Z; Koren G
    J Physiol; 2012 Mar; 590(5):1171-80. PubMed ID: 22183728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
    Leren IS; Hasselberg NE; Saberniak J; Håland TF; Kongsgård E; Smiseth OA; Edvardsen T; Haugaa KH
    JACC Cardiovasc Imaging; 2015 May; 8(5):501-510. PubMed ID: 25890583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome.
    Ziv O; Morales E; Song YK; Peng X; Odening KE; Buxton AE; Karma A; Koren G; Choi BR
    J Physiol; 2009 Oct; 587(Pt 19):4661-80. PubMed ID: 19675070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome.
    Aziz PF; Wieand TS; Ganley J; Henderson J; Patel AR; Iyer VR; Vogel RL; McBride M; Vetter VL; Shah MJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):867-73. PubMed ID: 21956039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
    Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
    J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology.
    Vaglio M; Couderc JP; McNitt S; Xia X; Moss AJ; Zareba W
    Heart Rhythm; 2008 Jan; 5(1):11-8. PubMed ID: 18180017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome.
    Brunner M; Peng X; Liu GX; Ren XQ; Ziv O; Choi BR; Mathur R; Hajjiri M; Odening KE; Steinberg E; Folco EJ; Pringa E; Centracchio J; Macharzina RR; Donahay T; Schofield L; Rana N; Kirk M; Mitchell GF; Poppas A; Zehender M; Koren G
    J Clin Invest; 2008 Jun; 118(6):2246-59. PubMed ID: 18464931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
    Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction.
    Odening KE; Kirk M; Brunner M; Ziv O; Lorvidhaya P; Liu GX; Schofield L; Chaves L; Peng X; Zehender M; Choi BR; Koren G
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H643-55. PubMed ID: 20581090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
    Bentzen BH; Bahrke S; Wu K; Larsen AP; Odening KE; Franke G; Storm vańs Gravesande K; Biermann J; Peng X; Koren G; Zehender M; Bode C; Grunnet M; Brunner M
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):223-30. PubMed ID: 21135701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane.
    Kojima A; Fukushima Y; Itoh H; Imoto K; Matsuura H
    Eur J Pharmacol; 2020 Sep; 883():173378. PubMed ID: 32710951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Long Heart Rate Variation Increases Dispersion of Action Potential Duration in Long QT Type 2 Transgenic Rabbit Model.
    Kim TY; Jeng P; Hwang J; Pfeiffer Z; Patel D; Cooper LL; Kossidas K; Centracchio J; Peng X; Koren G; Qu Z; Choi BR
    Sci Rep; 2019 Oct; 9(1):14849. PubMed ID: 31619700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
    Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
    BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
    Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics of families with long-QT syndrome.
    Moric-Janiszewska E; Głowacka M
    Cardiol J; 2012; 19(2):159-67. PubMed ID: 22461049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.